Essential Role of Chinese Medicines in Mesenchymal Stem Cells Transplantation for Treatment of Ischemic Stroke

Yong-hua ZHAO

doi:10.1007/s11655-019-2708-4

Your Location：

Home >

Browse articles >

Essential Role of Chinese Medicines in Mesenchymal Stem Cells Transplantation for Treatment of Ischemic Stroke

Feature Article | Updated：2021-08-27

- Essential Role of Chinese Medicines in Mesenchymal Stem Cells Transplantation for Treatment of Ischemic Stroke
- Essential Role of Chinese Medicines in Mesenchymal Stem Cells Transplantation for Treatment of Ischemic Stroke
- Chinese Journal of Integrative Medicine 2019年25卷第10期页码：723-727
- Affiliations：
  
  State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao (999078), China
- Author bio：
- Funds：
- DOI：10.1007/s11655-019-2708-4
  中图分类号：
- 纸质出版日期：2019-10-01，
  
  录用日期：2019-04-15
Scan for full text
Yong-hua ZHAO. Essential Role of Chinese Medicines in Mesenchymal Stem Cells Transplantation for Treatment of Ischemic Stroke[J]. Chinese Journal of Integrative Medicine, 2019,25(10):723-727.

Yong-hua ZHAO. Essential Role of Chinese Medicines in Mesenchymal Stem Cells Transplantation for Treatment of Ischemic Stroke[J]. Chinese Journal of Integrative Medicine, 2019,25(10):723-727.
Yong-hua ZHAO. Essential Role of Chinese Medicines in Mesenchymal Stem Cells Transplantation for Treatment of Ischemic Stroke[J]. Chinese Journal of Integrative Medicine, 2019,25(10):723-727. DOI： 10.1007/s11655-019-2708-4.

Yong-hua ZHAO. Essential Role of Chinese Medicines in Mesenchymal Stem Cells Transplantation for Treatment of Ischemic Stroke[J]. Chinese Journal of Integrative Medicine, 2019,25(10):723-727. DOI： 10.1007/s11655-019-2708-4.

摘要

Abstract

Ischemic stroke accounts for the majority of all strokes and has been primary causes of long-term disability and mortality in worldwide. Mesenchymal stem cell (MSC) therapy suggests significantly improved effects on neurological functional outcome

neurogenesis

angiogenesis

blood-brain barrier permeability

inflammatory injury

neuroprotection and so on

following stroke. However

the occurrence of adverse effects results in restriction of the therapy. Chinese medicine accumulates abundant clinical experiences on stroke for over two thousand years

and some formulae and active ingredients of Chinese medicines have presented obvious efficacies in clinical treatment. Therefore

based on Chinese medicine theory

we provide some ideas of screening agents for combination treatment of Chinese medicines and MSC for ischemic stroke

and summarize the potentials of Chinese medicines in MSC treatment and analyze the feasibilities of Chinese medicines against side effects of MSC therapy. Consequently

we propose Chinese medicines combing with MSC should be a promising approach to clinical stroke treatment in future.

关键词

Keywords

Chinese medicinescombination treatmentischemic strokemesenchymal stem cell

references

More>

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Analysis of Chinese Medical Syndrome Features of Ischemic Stroke Based on Similarity of Symptoms Subgroup

Electroacupuncture Attenuates Ischemic Brain Injury and Cellular Apoptosis via Mitochondrial Translocation of Cofilin

Revealing the Common Mechanisms of Scutellarin in Angina Pectoris and Ischemic Stroke Treatment via A Network Pharmacology Approach

Altered Brain Regional Homogeneity Following Contralateral Acupuncture at Quchi (LI 11) and Zusanli (ST 36) in Ischemic Stroke Patients with Left Hemiplegia: An fMRI Study

Effect of Tai Chi on Cardiac and Static Pulmonary Function in Older Community-Dwelling Adults at Risk of Ischemic Stroke: A Randomized Controlled Trial